Chad E. Beyer

3.8k total citations
53 papers, 2.6k citations indexed

About

Chad E. Beyer is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Chad E. Beyer has authored 53 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cellular and Molecular Neuroscience, 19 papers in Molecular Biology and 14 papers in Psychiatry and Mental health. Recurrent topics in Chad E. Beyer's work include Neurotransmitter Receptor Influence on Behavior (20 papers), Neuroscience and Neuropharmacology Research (13 papers) and Receptor Mechanisms and Signaling (11 papers). Chad E. Beyer is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (20 papers), Neuroscience and Neuropharmacology Research (13 papers) and Receptor Mechanisms and Signaling (11 papers). Chad E. Beyer collaborates with scholars based in United States, Canada and South Africa. Chad E. Beyer's co-authors include Jeffery D. Steketee, Lee E. Schechter, Sharon Rosenzweig‐Lipson, Robert H. Ring, Zoë A. Hughes, Brian J. Platt, Jessica E. Malberg, Meiyi Zhang, Jason M. Dwyer and Xavier Khawaja and has published in prestigious journals such as Analytical Chemistry, Brain Research and Journal of Medicinal Chemistry.

In The Last Decade

Chad E. Beyer

52 papers receiving 2.6k citations

Peers

Countries citing papers authored by Chad E. Beyer

Since Specialization

Citations

This map shows the geographic impact of Chad E. Beyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chad E. Beyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chad E. Beyer more than expected).

Fields of papers citing papers by Chad E. Beyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chad E. Beyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chad E. Beyer. The network helps show where Chad E. Beyer may publish in the future.

Co-authorship network of co-authors of Chad E. Beyer

This figure shows the co-authorship network connecting the top 25 collaborators of Chad E. Beyer. A scholar is included among the top collaborators of Chad E. Beyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chad E. Beyer. Chad E. Beyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Meta-analysis of the comparative efficacy of benzodiazepines and antidepressants for psychic versus somatic symptoms of generalized anxiety disorder 2024 ·Comprehensive Psychiatry ·Chad E. Beyer, (unknown), Taryn Williams, Dan J. Stein	1
2	Tygerberg Research Ubuntu-Inspired Community Engagement Model: Integrating Community Engagement into Genomic Biobanking 2019 ·Biopreservation and Biobanking ·Keymanthri Moodley, Chad E. Beyer	30
3	Antipsychotics for aggression in adults: A meta-analysis 2017 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Gerrit I. van Schalkwyk, Chad E. Beyer, Jessica A. Johnson, (unknown), Michael H. Bloch	27
4	The implications of Methylphenidate use by healthy medical students and doctors in South Africa 2014 ·BMC Medical Ethics ·Chad E. Beyer, Ciara Staunton, Keymanthri Moodley	26
5	Next generation antidepressants : moving beyond monoamines to discover novel treatment strategies for mood disorders 2010 ·Cambridge University Press eBooks ·Chad E. Beyer, Stephen M. Stahl	4
6	Depression-like phenotype following chronic CB1 receptor antagonism 2010 ·Neurobiology of Disease ·Chad E. Beyer, Jason M. Dwyer, Michael J. Piesla, Brian J. Platt, Ru Shen, Zia Ur Rahman, Karen K. L. Chan, Melissa T. Manners, Tarek A. Samad, Jeffrey D. Kennedy, Brendan Bingham, Garth T. Whiteside	124
7	Novel 1-aminoethyl-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines are potent 5-HT6 agonists 2009 ·Bioorganic & Medicinal Chemistry ·Ronald C. Bernotas, (unknown), Schuyler Antane, Derek C. Cole, Boyd L. Harrison, Albert J. Robichaud, (unknown), Deborah L. Smith, Brian J. Platt, Qian Lin, Ping Li, Joseph Coupet, Sharon Rosenzweig‐Lipson, Chad E. Beyer, Lee E. Schechter	15
8	The supra-additive hyperactivity caused by an amphetamine–chlordiazepoxide mixture exhibits an inverted-U dose response: Negative implications for the use of a model in screening for mood stabilizers 2009 ·Pharmacology Biochemistry and Behavior ·Michy P. Kelly, Sheree F. Logue, Jason M. Dwyer, Chad E. Beyer, (unknown), Cai Zhang, Zhi Liu, Adedayo Adedoyin, Sharon Rosenzweig‐Lipson, Thomas A. Comery	18
9	Acid sensing ion channel (ASIC) inhibitors exhibit anxiolytic-like activity in preclinical pharmacological models 2008 ·Psychopharmacology ·Jason M. Dwyer, Stacey J. Sukoff Rizzo, Sarah J. Neal Webb, Qian Lin, Flora Jow, Robert L. Arias, Sharon Rosenzweig‐Lipson, John Dunlop, Chad E. Beyer	38
10	Innovations in CNS drug discovery: differentiating strategies to treat depression 2007 ·Expert Opinion on Drug Discovery ·Chad E. Beyer, Zoë A. Hughes	1
11	Development of a liquid chromatography/tandem mass spectrometry method for the quantitation of acetylcholine and related neurotransmitters in brain microdialysis samples 2007 ·Journal of Pharmaceutical and Biomedical Analysis ·Meiyi Zhang, Zoë A. Hughes, Edward H. Kerns, Qian Lin, Chad E. Beyer	62
12	Neuropharmacological Profile of Novel and Selective 5-HT6 Receptor Agonists: WAY-181187 and WAY-208466 2007 ·Neuropsychopharmacology ·Lee E. Schechter, Qian Lin, Deborah L. Smith, Guoming Zhang, Qin Shan, Brian J. Platt, Michael R. Brandt, Lee A. Dawson, Derek C. Cole, (unknown), Albert J. Robichaud, Sharon Rosenzweig‐Lipson, Chad E. Beyer	176
13	Differentiating antidepressants of the future: Efficacy and safety 2006 ·Pharmacology & Therapeutics ·Sharon Rosenzweig‐Lipson, Chad E. Beyer, Zoë A. Hughes, Xavier Khawaja, (unknown), Jessica E. Malberg, Zia Ur Rahman, Robert H. Ring, Lee E. Schechter	144
14	Neurochemical changes in the RVM associated with peripheral inflammatory pain stimuli 2006 ·Brain Research ·Valerie A. Smith, Chad E. Beyer, Michael R. Brandt	12
15	α2A-adrenoceptors enhance the serotonergic effects of fluoxetine 2006 ·European Journal of Pharmacology ·Chad E. Beyer, Qian Lin, Sharon Rosenzweig‐Lipson, Lee E. Schechter	9
16	Measurement of neurotransmitters from extracellular fluid in brain by in vivo microdialysis and chromatography–mass spectrometry 2005 ·Journal of Pharmaceutical and Biomedical Analysis ·Meiyi Zhang, Chad E. Beyer	53
17	Nanoprobe NMR spectroscopy and in vivo microdialysis: new analytical methods to study brain neurochemistry 2003 ·Journal of Neuroscience Methods ·Purnima Khandelwal, Chad E. Beyer, Qian Lin, Paul McGonigle, Lee E. Schechter, A. Bach	23
18	Repeated exposure to inhaled toluene induces behavioral and neurochemical cross-sensitization to cocaine in rats 2001 ·Psychopharmacology ·Chad E. Beyer, David Stafford, Mark LeSage, John R. Glowa, Jeffery D. Steketee	48
19	Dopamine depletion in the medial prefrontal cortex induces sensitized-like behavioral and neurochemical responses to cocaine 1999 ·Brain Research ·Chad E. Beyer, Jeffery D. Steketee	61
20	Antioxidant properties of melatonin—an emerging mystery 1998 ·Biochemical Pharmacology ·Chad E. Beyer, Jeffery D. Steketee, D. Saphier	112

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact